Cellmid: Midkine Review Edition Published By Prestigious Journal
Cellmid Limited (ASX: CDY) advises that The British Journal of Pharmacology (BJP) has recently published a special editi…
Cellmid Limited (ASX: CDY) advises that The British Journal of Pharmacology (BJP) has recently published a special editi…
. - Fujikura exercises its Option to License Cellmid's MK diagnostic technology - Cellmid to receive milestone fee of…
. - Option to License agreement signed for the Company's diagnostic technology - Cellmid to receive an upfront option…
. - Anti-midkine antibodies reduced mortality rate and preserved kidney function in a mouse model of diabetic nephropat…
Cellmid Limited (ASX: CDY) advises that it has commenced the commercial launch of its Évolis(TM) hair growth products wi…
. - Midkine is confirmed to be part of Celera's six marker lung cancer diagnostic panel - New study using the test sh…
Cellmid Limited (ASX: CDY) advises that it has received TGA registration for its Évolis(TM) hair growth product range as…
. - GMP production of MK ELISA completed - Equivalent performance achieved - Important milestone in CE marking C…
BioGenes GmbH, a supplier of GMP compliant immunoassay and antibody services, has developed and optimized the first ever…